Genomics has entered into a multi-project research agreement with Fred Hutch for advancing single cell as well as spatial platforms in solid tumours and blood cancers.

Gilead Sciences has signed a five-year agreement extension with Cognizant to advance its DevOps environment and support the deployment of agentic AI tools across designated technology initiatives.

The US FDA has approved an expanded indication for Lilly's Jaypirca as a first-line treatment for adults with previously untreated CLL or SLL who do not have a 17p deletion.

New global strategic research and development facility in Massachusetts. Credit: Aram Boghosian/AstraZeneca. AstraZeneca has opened a new global strategic research and development (R&D) facility in ...

CSL and Alentis will work together to progress antifibrotic drug, lixudebart across multiple rare kidney and liver diseases.

The Nobel Prize committee says that optogenetics will lay the foundations for a new era in neuroscience, as pharma explores its role on treating ophthalmic conditions.

Illustration of New Albany International Business Park. Credit: Bayer AG. This investment adds to more than $7bn spent by the company on pharmaceutical research, development, and manufacturing in the ...

Molteni Farmaceutici focuses on specialty healthcare, hospital-based treatments, oncology supportive care, and pain management. Credit: Zerbor/Shutterstock.com. Pacira BioSciences has entered into an ...

The deal with Alector marks one of Roche’s most high-profile Parkinson’s deals in the past decade. Credit: JitendraJadhav/Shutterstock.com. Roche is paying up to ...

This agreement takes Lilly and Gate’s partnership into a new disease area. Credit: Jonathan Weiss / Shutterstock.com. Eli Lilly has expanded its partnership and licensing agreement with ...